Trials / Completed
CompletedNCT00212693
Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 165 (planned)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of ONO-2506PO in patients with Parkinson's Disease
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-2506PO |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2005-09-01
- First posted
- 2005-09-21
- Last updated
- 2012-10-11
Source: ClinicalTrials.gov record NCT00212693. Inclusion in this directory is not an endorsement.